These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23482667)

  • 1. Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications.
    Wong KK; Piert M
    J Nucl Med; 2013 Apr; 54(4):590-9. PubMed ID: 23482667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regarding Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications.
    Freesmeyer M
    J Nucl Med; 2013 Dec; 54(12):2190. PubMed ID: 24198385
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply: Regarding Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications.
    Wong KK; Piert M
    J Nucl Med; 2013 Dec; 54(12):2190-1. PubMed ID: 24198387
    [No Abstract]   [Full Text] [Related]  

  • 4. Atlas of sodium fluoride PET bone scans: atlas of NaF PET bone scans.
    Sheth S; Colletti PM
    Clin Nucl Med; 2012 May; 37(5):e110-6. PubMed ID: 22475920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice.
    Bastawrous S; Bhargava P; Behnia F; Djang DS; Haseley DR
    Radiographics; 2014; 34(5):1295-316. PubMed ID: 25208282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal PET with 18F-fluoride: applying new technology to an old tracer.
    Grant FD; Fahey FH; Packard AB; Davis RT; Alavi A; Treves ST
    J Nucl Med; 2008 Jan; 49(1):68-78. PubMed ID: 18077529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases.
    Li Y; Schiepers C; Lake R; Dadparvar S; Berenji GR
    Bone; 2012 Jan; 50(1):128-39. PubMed ID: 22001678
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Ahuja K; Sotoudeh H; Galgano SJ; Singh R; Gupta N; Gaddamanugu S; Choudhary G
    J Nucl Med Technol; 2020 Mar; 48(1):9-16. PubMed ID: 31811067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
    Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
    Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.
    Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS
    Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
    Iagaru A; Young P; Mittra E; Dick DW; Herfkens R; Gambhir SS
    Clin Nucl Med; 2013 Jul; 38(7):e290-6. PubMed ID: 23455520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-NaF PET/CT: EANM procedure guidelines for bone imaging.
    Beheshti M; Mottaghy FM; Paycha F; Behrendt FFF; Van den Wyngaert T; Fogelman I; Strobel K; Celli M; Fanti S; Giammarile F; Krause B; Langsteger W
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1767-1777. PubMed ID: 26201825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we achieve a radionuclide radiation dose equal to or less than that of 99mTc-hydroxymethane diphosphonate bone scintigraphy with a low-dose 18F-sodium fluoride time-of-flight PET of diagnostic quality?
    Ohnona J; Michaud L; Balogova S; Paycha F; Nataf V; Chauchat P; Talbot JN; Kerrou K
    Nucl Med Commun; 2013 May; 34(5):417-25. PubMed ID: 23470463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radionuclide studies of bone metabolism: do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover?
    Blake GM; Siddique M; Frost ML; Moore AE; Fogelman I
    Bone; 2011 Sep; 49(3):537-42. PubMed ID: 21689803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving Role of Molecular Imaging with (18)F-Sodium Fluoride PET as a Biomarker for Calcium Metabolism.
    Raynor W; Houshmand S; Gholami S; Emamzadehfard S; Rajapakse CS; Blomberg BA; Werner TJ; Høilund-Carlsen PF; Baker JF; Alavi A
    Curr Osteoporos Rep; 2016 Aug; 14(4):115-25. PubMed ID: 27301549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal bone and soft tissue distribution of fluorine-18-sodium fluoride and artifacts on 18F-NaF PET/CT bone scan: a pictorial review.
    Sarikaya I; Elgazzar AH; Sarikaya A; Alfeeli M
    Nucl Med Commun; 2017 Oct; 38(10):810-819. PubMed ID: 28777220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atlas of Extraosseous Findings Detected by 18F-NaF PET/CT Bone Scan.
    Woodhead GJ; Avery RJ; Kuo PH
    Clin Nucl Med; 2017 Dec; 42(12):930-938. PubMed ID: 29036001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant Findings on 18F-NaF and 99mTc-HDP Bone Scans in a Patient With ATTR Cardiac Amyloidosis.
    Ng QKT; Sethi P; Saunders TA; Pampaloni MH; Flavell RR
    Clin Nucl Med; 2018 Mar; 43(3):e89-e92. PubMed ID: 29261619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Glioblastoma With Calcified Region Imaged With 18F-NaF PET/CT.
    Ishimura M; Yamamoto Y; Mitamura K; Norikane T; Nishiyama Y
    Clin Nucl Med; 2018 Oct; 43(10):764-765. PubMed ID: 30080686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.